# Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma

> **NCT01284439** · NA · UNKNOWN · sponsor: **Mahidol University** · enrollment: 120 (estimated)

## Conditions studied

- Ocular Surface Disease
- Glaucoma

## Interventions

- **DRUG:** hydroxypropylmethylcellulose
- **DRUG:** sodium hyaluronate

## Key facts

- **NCT ID:** NCT01284439
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-02
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2011-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01284439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01284439, "Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01284439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*